Plain English Summary
Not provided at time of registration
Trial website
Contact information
Type
Scientific
Primary contact
Mr Stewart Richmond
ORCID ID
Contact details
301 Hertford Building
The University of Hull
Cottingham Road
Hull
HU6 7RX
United Kingdom
+44 (0)1482 463681
s.j.richmond@hull.ac.uk
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Application of static magnetic fields versus copper for the relief of pain in osteoarthritis: a randomised double-blind placebo controlled trial
Acronym
MACROPOD (Magnetic And Copper therapy for the Relief Of Pain in Osteoarthritis: a randomised Double-blind placebo-controlled trial)
Study hypothesis
Study aims:
1. To investigate the therapeutic efficacy of commercially available magnetic and copper bracelets as an adjunct to practitioner led management of osteoarthritic pain
2. To evaluate the potential economic impact of static magnetic therapy (SMT) and to gather evidence relating to safety of the devices under investigation
3. To address both local and more widespread needs in terms of providing rigorous scientific evidence relating to the efficacy of magnetic and copper bracelets
Ethics approval
Not provided at time of registration
Study design
Randomised double-blind placebo controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Not Specified
Patient information sheet
Trial participant information is available on http://www.hull.ac.uk/macropod/info.htm
Condition
Osteoarthritis
Intervention
The trial will use a randomised double-blind placebo controlled crossover design. All participants will undertake one of four randomly allocated treatment sequences consisting of four phases (one active and three control). During the active phase participants will wear the MagnaMax® static magnetic device for a period of four weeks. During the three control (placebo) phases, which will each last for four weeks, all participants will in turn wear: an otherwise identical low strength static magnetic device, a demagnetised device and a copper bracelet.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/01/2005
Overall trial end date
31/12/2006
Reason abandoned
Eligibility
Participant inclusion criteria
1. 18 years of age or over
2. Diagnosis of osteoarthritis
3. In receipt of prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and opioid/opioid compound analgesic medication
4. Responsible for administering own medication
5. Reporting pain associated with osteoarthritis
Participant type
Patient
Age group
Adult
Gender
Not Specified
Target number of participants
Between 48 to 60 patients identified as suffering from osteoarthritis within primary care.
Participant exclusion criteria
1. Confounding medical condition/disease
2. Pain lasting less than 6 weeks in total duration prior to recruitment
3. Pacemaker, insulin pump or similar device fitted
4. Pregnant women
Recruitment start date
01/01/2005
Recruitment end date
31/12/2006
Locations
Countries of recruitment
United Kingdom
Trial participating centre
301 Hertford Building
Hull
HU6 7RX
United Kingdom
Sponsor information
Organisation
The University of Hull (UK)
Sponsor details
Cottingham Road
Hull
HU6 7RX
United Kingdom
+44 (0)1482 463681
s.j.richmond@hull.ac.uk
Sponsor type
University/education
Website
Funders
Funder type
Hospital/treatment centre
Funder name
Wolds Primary Care Research Network (WOREN) and West Hull Primary Care Trust (uk)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary